Growing Geriatric Population to Boost Prostatic Artery Embolization Market Growth
Global Prostatic Artery Embolization Market, by Region (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa) – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2020 – 2027
The global prostatic artery embolization market is estimated to exhibit a CAGR of 4.5% over the forecast period, as highlighted in a new report published by Coherent Market Insights.
Prostatic artery embolization (PAE) is emerging as an effective minimally invasive treatment for lower urinary tract symptoms caused by benign prostatic hyperplasia. PAE has a high rate of success, with over 90% of individuals experiencing relief in the first year. Prostatic artery embolization is a safe treatment with long term efficacy. It can be a viable therapeutic option for patients with severe lower urinary tract symptoms (LUTS) from giant prostatic hyperplasia (GPH) whom fail medical therapy and are not candidates for surgical treatments.
𝐆𝐞𝐭 𝐅𝐮𝐥𝐥 𝐏𝐃𝐅 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭: (𝐈𝐧𝐜𝐥𝐮𝐝𝐢𝐧𝐠 𝐅𝐮𝐥𝐥 𝐓𝐎𝐂, 𝐋𝐢𝐬𝐭 𝐨𝐟 𝐓𝐚𝐛𝐥𝐞𝐬 & 𝐅𝐢𝐠𝐮𝐫𝐞𝐬, 𝐂𝐡𝐚𝐫𝐭) @ https://www.coherentmarketinsights.com/insight/request-pdf/4108
Benign prostatic hyperplasia affects more than 50% of men by the age of 60 years and up to 80% of men older than 70 years, and its prevalence is increasing as the population ages. Benign prostatic hyperplasia (BPH) is an enlargement of the prostate caused by an overgrowth of cells (called hyperplasia) in the prostate.
Major players operating in the global prostatic artery embolization market are GE Healthcare, QXMedical, LLC, Embolx, Inc., Terumo Corporation, Merit Medical Systems, Inc., Mentice AB, Siemens Healthineers AG, and Boston Scientific Corporation, among others.
Key Market Drivers:
Increasing prevalence of benign prostate hyperplasia across the globe is expected to augment the growth of the prostatic artery embolization market during the forecast period. For instance, worldwide, as many as 30 million men have symptoms related to benign prostatic hyperplasia. According to the National Institutes of Health (NIH), BPH affects about 50% of men between the ages of 51 and 60 and up to 90% of men older than 80.
𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐂𝐨𝐯𝐢𝐝𝟏𝟗 𝐈𝐦𝐩𝐚𝐜𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/4108
Moreover, growing adoption of prostatic artery embolization procedures is expected to boost the growth of the prostatic artery embolization market. For instance, in July 2018, physicians at UC San Diego Health started offering prostate artery embolization (PAE) as a new treatment option for men with benign prostatic hyperplasia (BPH). The minimally invasive procedure is an alternative to surgery, with no hospital stay, little operative pain, and lower cost.
COVID-19 Impact Analysis:
The outbreak of COVID-19 has had severe impact on the growth of various markets, and it is also expected to hinder growth of the prostatic artery embolization market during the forecast period. Moreover, safety measures enforced by several countries, as well as, safety precautions suggested by World Health Organization (WHO), to reduce the risk of spread of COVID-19 infection while performing surgical procedures it has become very difficult to conduct surgical procedures, such as prostatic artery embolization.
- The prostatic artery embolization market is expected to exhibit a CAGR of 4.5 % during the forecast period due to the growing geriatric population around the world. For instance, according to WHO, the world’s population of people aged 60 years and older will double (2.1 billion) by 2050, and the number of individuals aged 80 years or older is expected to triple between 2020 and 2050, to reach 426 million.
- Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the prostatic artery embolization market owing to the high prevalence of benign prostate hyperplasia, growing geriatric population, and growing adoption of prostatic artery embolization procedures in these regions.
- For instance, as many as 14 million men in the United States have symptoms of BPH. In July 2018, the University of California, San Diego (UCSD) researchers announced that the Food and Drug Administration (FDA) approved prostate artery embolization, or PAE, to treat benign prostate hyperplasia, or enlarged prostates. Moreover, PAE has been available in Europe as a treatment option for an enlarged prostate for several years.
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐚𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐅𝐅
𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/4108
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Prostatic Artery Embolization Market Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Prostatic Artery Embolization Market Industry Impact
Chapter 2 Global Prostatic Artery Embolization Market Competition by Types, Applications, and Top Regions and Countries
2.1 Global Prostatic Artery Embolization Market (Volume and Value) by Type
2.3 Global Prostatic Artery Embolization Market (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Prostatic Artery Embolization Market Sales, Consumption, Export, Import by Regions
Chapter 5 North America Prostatic Artery Embolization Market Market Analysis
Chapter 6 East Asia Prostatic Artery Embolization Market Market Analysis
Chapter 7 Europe Prostatic Artery Embolization Market Market Analysis
Chapter 8 South Asia Prostatic Artery Embolization Market Market Analysis
Chapter 9 Southeast Asia Prostatic Artery Embolization Market Market Analysis
Chapter 10 Middle East Prostatic Artery Embolization Market Market Analysis
Chapter 11 Africa Prostatic Artery Embolization Market Market Analysis
Chapter 12 Oceania Prostatic Artery Embolization Market Market Analysis
Chapter 13 South America Prostatic Artery Embolization Market Market Analysis
Chapter 14 Company Profiles and Key Figures in Prostatic Artery Embolization Market Business
Chapter 15 Global Prostatic Artery Embolization Market Market Forecast (2021-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027